In the absence of diagnostic biomarkers, AIH is divided according to their signature autoantibodies into type-1 AIH with ANA, ASMA, and SLA antibodies and type-2 AIH with anti-LKM1 or anti-LC1 antibodies. Here, DNAL1 is linked to autoimmune hepatitis.